SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C38 - Case Studies: Neurologic Consultations in Cancer Patients I

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): Neuro-oncology
Director(s): Amy Pruitt MD
Description: Faculty will discuss 10-12 cases representing such problems as stroke in a cancer patient, complications of new immune checkpoint inhibitors, acute mental status changes in transplant recipients, primary CNS lymphoma and its mimics, and neurologic problems of cancer survivors such as chemobrain, secondary neoplasms, and infections. Some cases will address the evolving role of palliative care consultation in the management of these patients. This program complements C56: Case Studies: Neurologic Consultations in Cancer Patients II, but covers independent topics.
Completion Message: Participants should be able to evaluate causes of stroke in cancer patients and explain appropriate anticoagulation strategies, recognize the many variations of presentation of primary CNS lymphoma, recognize and treat novel neurologic complications in patients receiving immune checkpoint inhibitors, recognize toxicities of drugs used in hematopoietic cell transplantation, and perform a thorough screen for neurologic issues in long-term survivors of CNS cancer treatment.
CME Credits: 2
Core Competencies: Interpersonal and Communication Skills, Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:30 PM Medical Problems Arising During the Course of Tumor Treatment Jaishri Blakeley MD 
1:30 PM - 2:00 PM Diagnostic Dilemmas David Schiff MD, FAAN 
2:00 PM - 3:00 PM Tumor Board: Eight Important Diagnoses for the Consulting Neurologist Amy Pruitt MD 


Speaker Disclosure
Jaishri Blakeley, MD Dr. Blakeley has received personal compensation for activities with Abbvie, Inc. Dr. Blakeley has received research support from GlaxoSmithKline.

Amy A. Pruitt, MD Dr. Pruitt has nothing to disclose.

David Schiff, MD, FAAN Dr. Schiff has received personal compensation for activities with Genentech, Oxigene, Vascular Biogenics, and Orbus Therapeutics as an advisory board member and a DSMC.

Register Now

Related Courses

Sunday April 22, 2018

9:15 AM-12:00 PM
PL2 Presidential Plenary Session

Wednesday April 25, 2018

1:00 PM-3:00 PM
C149 Neurologic Consultations in Cancer Patients I Amy Pruitt MD
3:30 PM-5:30 PM
C164 Neurologic Consultations in Cancer Patients II Patrick Wen MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C178 Neuro-oncology in 2018: Navigating Current Trends Maciej Mrugala MD
1:00 PM-3:00 PM
C190 Neuro-oncologic Predicaments in the Hospital Setting Na Tosha Gatson MD, PhD
3:30 PM-5:30 PM
N6 Neuroscience in the Clinic: Neurologic Complications of Cancer Immunotherapy: A New Frontier in Neuro-Inflammation Antonio Omuro MD,
Andreas Hottinger MD


Forgot Password?